| | | | | |
PRQR ProQR Therapeutics N.V. Ordinary Shares | €1,3123 | +3,74% | €141,43M | €424,71K | |
NAZ Nuveen Arizona Quality Municipal Income Fund | €11,3328 | +0,23% | €141,42M | €20,87K | |
| €2,0953 | +0,21% | €141,35M | €226,85K | |
AMWL American Well Corporation | €7,5311 | +3,45% | €141,33M | €40,86K | |
| €46,3035 | +2,34% | €141,27M | €9,64K | |
SPRO Spero Therapeutics, Inc. Common Stock | €2,5600 | +6,25% | €141,00M | €769,85K | |
| €1,5369 | +5,06% | €140,80M | €185,99K | |
NMP NMP Acquisition Corp. Class A Ordinary Shares | €8,7900 | -0,24% | €140,45M | €1,27K | |
GLQ Clough Global Equity Fund | €7,4786 | +0,59% | €140,44M | €79,12K | |
MNSB MainStreet Bancshares, Inc. Common Stock | €20,1314 | +3,20% | €140,18M | €25,80K | |
ORMP Oramed Pharmaceuticals Inc. | €3,2940 | +4,88% | €139,81M | €111,30K | |
CPSH CPS Technologies Corp. Common Stock | €7,0785 | +4,66% | €139,76M | €1,18M | |
NNY Nuveen New York Municipal Value Fund | €7,3659 | -0,46% | €139,59M | €14,45K | |
VTN Invesco Trust for Investment Grade New York Municipals | €9,5214 | +0,32% | €139,48M | €7,64K | |
KORE KORE Group Holdings, Inc. | €7,9037 | -0,05% | €138,93M | €10,42K | |
